Prescription drugs

FILE - This May 8, 2007, file photo shows the Purdue Pharma logo at its offices in Stamford, Conn. (AP Photo/Douglas Healey, File)
September 17, 2019 - 5:24 pm
WHITE PLAINS, N.Y. (AP) — A judge cleared the way Tuesday for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed against it in a reckoning over the opioid crisis. At the first court hearing since the Chapter 11...
Read More
FILE - In this Aug. 17, 2018, file photo, Lynn Wencus of Wrentham, Mass., holds a sign with a picture of her son Jeff and wears a sign of others' loved ones lost to OxyContin and other opioids during a protest at Purdue Pharma LLP headquarters in Stamford, Conn. Some of the money in Purdue Pharma’s proposed multibillion-dollar opioid settlement would come from the continued sale of opioids. “It’s blood money paying for blood money,” said Wencus. “It’s ludicrous. The whole thing would be almost comical if we weren’t talking about human lives here.” (AP Photo/Jessica Hill, File)
September 17, 2019 - 4:42 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - In this Aug. 17, 2018, file photo, Lynn Wencus of Wrentham, Mass., holds a sign with a picture of her son Jeff and wears a sign of others' loved ones lost to OxyContin and other opioids during a protest at Purdue Pharma LLP headquarters in Stamford, Conn. Some of the money in Purdue Pharma’s proposed multibillion-dollar opioid settlement would come from the continued sale of opioids. “It’s blood money paying for blood money,” said Wencus. “It’s ludicrous. The whole thing would be almost comical if we weren’t talking about human lives here.” (AP Photo/Jessica Hill, File)
September 17, 2019 - 4:20 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 17, 2019 - 3:03 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 17, 2019 - 7:29 am
NEW YORK (AP) — Purdue Pharma gets its day in court Tuesday after the OxyContin maker filed for bankruptcy and negotiated a potential multi-billion dollar settlement to resolve thousands of lawsuits. An initial hearing will be held in federal court in White Plains, New York, for the Chapter 11...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 17, 2019 - 4:11 am
NEW YORK (AP) — Purdue Pharma gets its day in court Tuesday after the OxyContin maker filed for bankruptcy and negotiated a potential multi-billion dollar settlement to resolve thousands of lawsuits. An initial hearing will be held in federal court in White Plains, New York, for the Chapter 11...
Read More
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Purdue Pharma, the company which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15, 2019, seeking Chapter 11 bankruptcy protection. (AP Photo/Toby Talbot, File)
September 16, 2019 - 5:11 pm
BOSTON (AP) — OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation's deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity. Whether the company can pull it off...
Read More
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Purdue Pharma, the company which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15, 2019, seeking Chapter 11 bankruptcy protection. (AP Photo/Toby Talbot, File)
September 16, 2019 - 4:48 pm
BOSTON (AP) — OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation's deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity. Whether the company can pull it off...
Read More
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Purdue Pharma, the company which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15, 2019, seeking Chapter 11 bankruptcy protection. (AP Photo/Toby Talbot, File)
September 16, 2019 - 4:00 pm
BOSTON (AP) — OxyContin maker Purdue Pharma has set in motion a multibillion-dollar plan to settle thousands of lawsuits over the deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity. Whether the company can pull it off remains to be...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 16, 2019 - 11:24 am
Purdue Pharma filed for bankruptcy in the first step in a complex, multibillion-dollar plan by the maker of OxyContin to settle thousands of lawsuits brought against it by state and local governments over the nation's deadly opioid disaster. The company and members of the Sackler family, which owns...
Read More

Pages